S odium‐glucose co‐transporter‐2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis-Reference-Cited by-同舟云学术

S odium‐glucose co‐transporter‐2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta‐analysis

Published:2021-03-30 Issue:7 Volume:23 Page:1672-1676
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Giugliano Dario¹²^ORCID,Longo Miriam¹²,Caruso Paola¹²,Maiorino Maria Ida³^ORCID,Bellastella Giuseppe²,Esposito Katherine³

Affiliation:

1. Division of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Sciences University of Campania “L. Vanvitelli” Naples Italy

2. Ph.D. of Translational Medicine, Chair of Endocrinology and Metabolic Diseases, Department of Advanced Medical and Surgical Sciences University of Campania “L. Vanvitelli” Naples Italy

3. Diabetes Unit, Department of Advanced Medical and Surgical Sciences University of Campania “L. Vanvitelli” Naples Italy

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14374

Reference22 articles.

1. Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus

2. SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

3. Relationship between improvement of glycaemic control and reduction of major cardiovascular events in 15 cardiovascular outcome trials: A meta‐analysis with meta‐regression

4. Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

5. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on evidence-based clinical application of sodium-glucose cotransporter inhibitors: Insight to uncommon cardiovascular disease scenarios in diabetes;World Journal of Diabetes;2024-07-15

2. Therapy of Type 2 Diabetes;Experimental and Clinical Endocrinology & Diabetes;2024-04-10

3. Therapie des Typ-2-Diabetes;Die Diabetologie;2024-01-30

4. GLP-1 receptor agonists, SGLT2 inhibitors and noncardiovascular mortality in type 2 diabetes: Insights from a meta-analysis;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01

5. Applications of Clinical Decision Support Systems in Diabetes Care: Scoping Review;Journal of Medical Internet Research;2023-12-08